Waterloo Capital, L.P.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1730942 Austin, TX

Position in REGN

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$211,380

-$98,448 QoQ

Shares Held

339

-15.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#320

of 454 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Waterloo Capital, L.P. holds $7,809,642 across 5 Biotechnology names. REGN ranks #4 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	9,926	$5,329,765
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,651	$1,813,561
3	INCY	Incyte Corp	2,737	$310,266
4	REGN	Regeneron Pharmaceuticals, Inc. This page	339	$211,380
5	DRTS	Alpha Tau Medical Ltd.	11,500	$144,670

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$211,380	339	-15.5%	Shares	Sole	2026-07-29
2026-03-31	$309,828	401	-46.2%	Shares	Sole	2026-05-12
2025-12-31	$575,043	745	—	Shares	Sole	2026-02-10
No filing history on record for this holder in this stock.